• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病细胞产生活性尿激酶:与实体瘤细胞系的新区别。

Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors.

作者信息

Stephens R, Alitalo R, Tapiovaara H, Vaheri A

机构信息

Department of Virology, University of Helsinki, Finland.

出版信息

Leuk Res. 1988;12(5):419-22. doi: 10.1016/0145-2126(88)90061-6.

DOI:10.1016/0145-2126(88)90061-6
PMID:3379974
Abstract

A new screening test is described which enabled rapid determination of the proportion of single-chain and two-chain urokinase produced in the culture supernatants of 18 human cell lines. A clear distinction was found between two groups of cell lines: cells derived from ten solid tumors produced almost exclusively single-chain proenzyme, while the majority of the enzyme found in cultures of eight leukemia cell lines was in the active, two-chain form.

摘要

本文描述了一种新的筛选试验,该试验能够快速测定18种人类细胞系培养上清液中产生的单链和双链尿激酶的比例。在两组细胞系之间发现了明显的差异:来自10种实体瘤的细胞几乎只产生单链酶原,而在8种白血病细胞系培养物中发现的大多数酶是活性双链形式。

相似文献

1
Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors.白血病细胞产生活性尿激酶:与实体瘤细胞系的新区别。
Leuk Res. 1988;12(5):419-22. doi: 10.1016/0145-2126(88)90061-6.
2
Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1.人T细胞相关丝氨酸蛋白酶HuTSP-1对尿激酶原的激活作用。
FEBS Lett. 1990 Jan 15;260(1):141-4. doi: 10.1016/0014-5793(90)80087-y.
3
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.从人癌细胞释放的可溶性尿激酶受体:异种移植肿瘤研究的血浆参数
Br J Cancer. 1999 Sep;81(2):203-11. doi: 10.1038/sj.bjc.6690678.
4
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.人肉瘤细胞上尿激酶原和纤溶酶原的激活:一个具有表面结合反应物的蛋白水解系统。
J Cell Biol. 1989 May;108(5):1987-95. doi: 10.1083/jcb.108.5.1987.
5
Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.尿激酶与尿激酶受体:与人膀胱癌细胞系体外侵袭性的关联。
J Natl Cancer Inst. 1997 May 21;89(10):709-17. doi: 10.1093/jnci/89.10.709.
6
Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts.血小板衍生生长因子亚型对牙周膜和成纤维细胞纤溶酶原激活的影响。
J Periodontal Res. 2008 Jun;43(3):334-42. doi: 10.1111/j.1600-0765.2007.01038.x.
7
Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.关于:尿激酶与尿激酶受体:与人类膀胱癌细胞系体外侵袭性的关联。
J Natl Cancer Inst. 1997 Nov 5;89(21):1630-1. doi: 10.1093/jnci/89.21.1630.
8
Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.缺氧和复氧对人头颈部肿瘤细胞中尿激酶型纤溶酶原激活物、其抑制剂1型纤溶酶原激活物抑制剂及尿激酶型纤溶酶原激活物受体表达水平的影响。
Oncol Rep. 2007 May;17(5):1259-68.
9
Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.12-O-十四烷酰佛波醇-13-乙酸酯诱导的K562白血病细胞培养物中蛋白水解活性的下调:1型纤溶酶原激活物抑制剂过量导致活性尿激酶耗竭
J Cell Physiol. 1989 Jul;140(1):119-30. doi: 10.1002/jcp.1041400115.
10
Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.人早幼粒细胞白血病细胞系HL-60刺激产生尿激酶和纤溶酶原激活物抑制剂-2 。
Thromb Res. 1988 Jul 15;51(2):175-85. doi: 10.1016/0049-3848(88)90061-8.

引用本文的文献

1
Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.急性早幼粒细胞白血病血栓性出血性素质的发病机制与治疗。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011068. doi: 10.4084/MJHID.2011.068. Epub 2011 Dec 21.
2
The hypercoagulable state of malignancy: pathogenesis and current debate.恶性肿瘤的高凝状态:发病机制与当前争论
Neoplasia. 2002 Nov-Dec;4(6):465-73. doi: 10.1038/sj.neo.7900263.
3
Pathogenesis of thrombosis in patients with malignancy.恶性肿瘤患者血栓形成的发病机制。
Int J Hematol. 2001 Feb;73(2):137-44. doi: 10.1007/BF02981929.
4
Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.神经系统疾病患者脑脊液中组织型纤溶酶原激活物的活性
J Clin Pathol. 1996 Jul;49(7):577-80. doi: 10.1136/jcp.49.7.577.
5
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.人肉瘤细胞上尿激酶原和纤溶酶原的激活:一个具有表面结合反应物的蛋白水解系统。
J Cell Biol. 1989 May;108(5):1987-95. doi: 10.1083/jcb.108.5.1987.
6
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.人横纹肌肉瘤细胞表面的纤溶酶原激活物原激活:重组2类纤溶酶原激活物抑制剂对新形成的尿激酶型纤溶酶原激活物的定位和失活作用
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2230-4. doi: 10.1073/pnas.87.6.2230.
7
Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.α2-巨球蛋白将纤溶酶原激活限制在RC2A白血病细胞表面。
Cell Regul. 1991 Dec;2(12):1057-65. doi: 10.1091/mbc.2.12.1057.
8
The plasminogen-plasmin system in malignancy.恶性肿瘤中的纤溶酶原-纤溶酶系统
Cancer Metastasis Rev. 1992 Nov;11(3-4):291-311. doi: 10.1007/BF01307184.